253 related articles for article (PubMed ID: 37705592)
1. Preclinical and Clinical Use of Indigenously Developed
Hazari PP; Yadav SK; Kumar PK; Dhingra V; Rani N; Kumar R; Singh B; Mishra AK
ACS Pharmacol Transl Sci; 2023 Sep; 6(9):1233-1247. PubMed ID: 37705592
[TBL] [Abstract][Full Text] [Related]
2. LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation.
Sharma S; Singh B; Mishra AK; Rathod D; Hazari PP; Chuttani K; Chopra S; Singh PM; Abrar ML; Mittal BR; Singh G
Cancer Biother Radiopharm; 2014 Sep; 29(7):283-8. PubMed ID: 25203145
[TBL] [Abstract][Full Text] [Related]
3. [
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
[No Abstract] [Full Text] [Related]
4. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MDM Brain SPECT for the Detection of Recurrent/Remnant Glioma-Comparison With ceMRI and 18F-FLT PET Imaging: Initial Results.
Singh B; Kumar N; Sharma S; Watts A; Hazari PP; Rani N; Vyas S; Anish B; Mishra AK
Clin Nucl Med; 2015 Oct; 40(10):e475-9. PubMed ID: 26204205
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Recurrent/Residual Glioma From Radiation Necrosis Using Semi Quantitative 99mTc MDM (Bis-Methionine-DTPA) Brain SPECT/CT and Dynamic Susceptibility Contrast-Enhanced MR Perfusion: A Comparative Study.
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Singh H; Kumar G; Radotra B; Kumar M; Bhattacharya A; Sharma R; Kohli A; Chhabra R; Gupta SK; Mishra AK
Clin Nucl Med; 2018 Mar; 43(3):e74-e81. PubMed ID: 29356734
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiolabeling and evaluation of [
Dinmohammadi F; Erfani M; Shamsaei M; Shirmardi SP; Goudarzi M
Bioorg Chem; 2023 Jan; 130():106237. PubMed ID: 36402025
[TBL] [Abstract][Full Text] [Related]
8. [
Jaswal AP; Hazari PP; Prakash S; Sethi P; Kaushik A; Roy BG; Kathait S; Singh B; Mishra AK
ACS Omega; 2022 Apr; 7(15):12509-12523. PubMed ID: 35474820
[TBL] [Abstract][Full Text] [Related]
9. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
10. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. LAT1 targeted delivery of methionine based imaging probe derived from M(III) metal ions for early diagnosis of proliferating tumours using molecular imaging modalities.
Hazari PP; Prakash S; Meena VK; Jaswal A; Khurana H; Mishra SK; Bhonsle HK; Singh L; Mishra AK
Curr Cancer Drug Targets; 2015; 14(9):817-31. PubMed ID: 25329672
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
[TBL] [Abstract][Full Text] [Related]
15. Design of
Li Y; Zhao L; Xu X; Sun N; Qiao W; Xing Y; Shen M; Zhu M; Shi X; Zhao J
J Biomed Nanotechnol; 2019 Jun; 15(6):1201-1212. PubMed ID: 31072428
[TBL] [Abstract][Full Text] [Related]
16. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
